Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Specialty Chemicals

Alto Ingredients, Inc. produces and markets specialty alcohols and essential ingredients in the United States. It operates in two segments, Production and Marketing. The company offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners; alcoholic beverages, flavor extracts, and vinegar, as well as corn germ used for corn oils and carbon dioxide. It also provides essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed used in commercial animal feed and pet food; and fuel-grade ethanol used as transportation fuel and distillers corn oil used as a biodiesel feedstock, as well as fuel-grade ethanol produced by third parties. In addition, the company offers transportation, storage, and delivery services through third-party service providers. It sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry and biodiesel customers. The company operates seven ethanol production facilities, including three plants in the Midwestern states of Illinois; and four plants located in the Western states of California, Oregon, and Idaho. The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc...
Website: altoingredients.com



Growth: Bad revenue growth rate -4.4%, there is acceleration compared to average historical growth rates -12.4%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -0.9%. On average the margin is improving steadily. Gross margin is low, +9.8%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 20% of quarters (showing a gain of -$0.17 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -5.5% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 241.8% higher than minimum and 45.7% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 0.9x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: ALTO
Share price, USD:  (0.0%)2.67
year average price 1.49  


year start price 1.49 2025-02-08

min close price 0.78 2025-04-21

max close price 3.08 2025-12-24

current price 2.67 2026-02-07
Common stocks: 74 777 000

Dividend Yield:  0.0%
Last revenue growth (y/y):  -4.4%
Last growth of EBITDA (y/y):  +163.6%
Historical revenue growth:  -12.4%
Historical growth of EBITDA:  -1.2%
EV / Sales: 0.3x
Margin (EBITDA LTM / Revenue): -0.9%
Fundamental value created in LTM:
Market Cap ($m): 200
Net Debt ($m): 84
EV (Enterprise Value): 284
Price to Book: 0.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-28zacks.com

Is Western Production a Core Earnings and Growth Pillar for ALTO?

2026-01-22zacks.com

Is the Pekin Segment the Anchor of Alto Ingredients' Growth Strategy?

2026-01-15zacks.com

Why Alto Ingredients Remains Unprofitable Despite Market Leadership

2025-12-31zacks.com

Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year?

2025-12-15zacks.com

Are Consumer Discretionary Stocks Lagging Alto Ingredients (ALTO) This Year?

2025-11-27zacks.com

Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year?

2025-11-12zacks.com

Alto Ingredients (ALTO) Just Flashed Golden Cross Signal: Do You Buy?

2025-11-11zacks.com

Is Alto Ingredients (ALTO) Outperforming Other Consumer Discretionary Stocks This Year?

2025-11-05zacks.com

Alto Ingredients (ALTO) Q3 Earnings and Revenues Surpass Estimates

2025-10-20businesswire.com

Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164
fillingDate 2025-11-07 2025-08-08 2024-11-08 2024-08-08 2024-05-08 2023-11-08 2023-08-08 2023-05-09 2022-11-09
acceptedDate 2025-11-07 16:16:19 2025-08-08 16:11:46 2025-03-13 16:15:45 2024-11-08 16:20:26 2024-08-08 16:35:14 2024-05-08 16:15:43 2024-03-14 06:20:03 2023-11-08 16:32:32 2023-08-08 16:16:45 2023-05-09 16:36:10 2023-03-14 16:36:21 2022-11-08 20:38:21 2022-03-14 19:07:48 2021-03-26 16:16:56
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 241M 218M 965M 252M 236M 241M 1 223M 318M 317M 314M 1 336M 337M 1 208M 897M
costOfRevenue 217M 220M 956M 246M 232M 240M 1 207M 314M 300M 317M 1 363M 357M 1 140M 844M
grossProfit 23M -2M 10M 6M 5M 938 000 16M 4M 17M -3M -28M -20M 68M 53M
grossProfitRatio 0.097 -0.009 0.024 0.02 0.004 0.013 0.054 -0.01 -0.059
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 7M 6M 30M 8M 9M 8M 33M 8M 8M 8M 28M 7M 29M 32M
otherExpenses 0 0 32M 0 -29 000 241 000 7M 26 000 59 000 19 000 6M 0 -1M 11M
operatingExpenses 7M 6M 61M 8M 9M 8M 40M 6M 8M 8M 34M 7M 28M 43M
costAndExpenses 224M 227M 1 017M 253M 241M 248M 1 247M 320M 308M 325M 1 397M 364M 1 168M 887M
interestIncome 0 0 0 0 0 0 0 2M 2M 0 0 0 0 0
interestExpense 3M 3M 8M 2M 2M -2M 7M 2M 2M 2M 2M 340 000 4M 18M
depreciationAndAmortization 6M 6M 24M 6M 6M 6M 23M 3M 6M 593 000 25M -456 000 23M 30M
ebitda 23M -2M -27M 5M 5M -1M 3M -1M 15M -11M -13M -28M 74M 31M
ebitdaratio 0.097 -0.008 0.022 0.008 -0.005 -0.005 0.047 -0.035 -0.082
operatingIncome 17M -8M -52M -720 000 -4M -7M -24M -4M 9M -12M -61M -27M 40M 10M
operatingIncomeRatio 0.07 -0.037 -0.003 -0.018 -0.029 -0.014 0.029 -0.037 -0.081
totalOtherIncomeExpensesNet -3M -3M -7M -2M -2M -5M -4M 26 000 59 000 -2M 22M -796 000 7M -27M
incomeBeforeTax 14M -11M -59M -2M -3M -12M -28M -3M 8M -13M -40M -28M 48M -17M
incomeBeforeTaxRatio 0.059 -0.05 -0.01 -0.013 -0.049 -0.011 0.024 -0.042 -0.083
incomeTaxExpense 0 0 173 000 0 0 6M 97 000 -812 000 2M -5M 2M -6M 1M -17 000
netIncome 14M -11M -59M -2M -3M -12M -28M -3M 8M -8M -42M -22M 46M -15M
netIncomeRatio 0.059 -0.05 -0.01 -0.013 -0.049 -0.011 0.024 -0.024 -0.065
eps 0.19 -0.15 -0.82 -0.037 -0.042 -0.16 -0.4 -0.048 0.1 -0.1 -0.58 -0.3 0.62 -0.29
epsdiluted 0.19 -0.15 -0.037 -0.042 -0.16 -0.048 0.1 -0.1 -0.3
weightedAverageShsOut 74M 74M 73M 74M 73M 73M 73M 73M 74M 74M 72M 73M 71M 59M
weightedAverageShsOutDil 74M 74M 73M 74M 73M 73M 73M 73M 74M 74M 72M 73M 72M 59M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-13 2024-03-14 2023-03-14 2022-03-15 2021-03-26
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -8M -7M -2M -4M -18M
ebit -51M -20M -38M 51M 644 000
nonOperatingIncomeExcludingInterest -508 000 -3M -24M -11M 9M
netIncomeFromContinuingOperations -59M -28M -42M 46M -17M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 1M
bottomLineNetIncome -60M -29M -43M 44M -16M
epsDiluted -0.82 -0.4 -0.58 0.61 -0.29

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164
fillingDate 2025-11-07 2025-08-08 2024-11-08 2024-08-08 2024-05-08 2023-11-08 2023-08-08 2023-05-09 2022-11-09
acceptedDate 2025-11-07 16:16:19 2025-08-08 16:11:46 2025-03-13 16:15:45 2024-11-08 16:20:26 2024-08-08 16:35:14 2024-05-08 16:15:43 2024-03-14 06:20:03 2023-11-08 16:32:32 2023-08-08 16:16:45 2023-05-09 16:36:10 2023-03-14 16:36:21 2022-11-08 20:38:21 2022-03-14 19:07:48 2021-03-26 16:16:56
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 33M 30M 35M 38M 28M 42M 30M 26M 23M 21M 36M 28M 51M 48M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 33M 30M 35M 38M 28M 42M 30M 26M 23M 21M 36M 28M 51M 48M
netReceivables 55M 57M 58M 52M 64M 58M 59M 66M 63M 67M 69M 76M 87M 43M
inventory 53M 0 50M 48M 49M 43M 53M 57M 71M 67M 67M 61M 54M 38M
otherCurrentAssets 10M 62M 10M 7M 12M 8M 27M 6M 6M 5M 27M 9M 38M 84M
totalCurrentAssets 151M 150M 153M 145M 154M 151M 169M 168M 180M 172M 199M 186M 230M 214M
propertyPlantEquipmentNet 222M 0 235M 258M 265M 270M 271M 272M 271M 267M 258M 246M 236M 241M
goodwill 0 0 0 0 0 0 0 6M 6M 6M 6M 6M 0 0
intangibleAssets 8M 8M 5M 0 8M 8M 8M 9M 9M 9M 9M 9M 3M 3M
goodwillAndIntangibleAssets 8M 8M 5M 8M 8M 8M 8M 15M 15M 15M 15M 15M 3M 3M
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 8M 235M 9M 6M 5M 5M 6M 6M 6M 6M 6M 7M 17M 20M
totalNonCurrentAssets 238M 243M 248M 272M 279M 284M 285M 293M 292M 288M 279M 268M 255M 263M
otherAssets 0 0 0 1 0 0 0 0 0 0 0 0 0 0
totalAssets 388M 393M 401M 417M 432M 435M 454M 461M 471M 460M 478M 455M 485M 477M
accountPayables 16M 16M 20M 17M 20M 19M 21M 24M 26M 24M 28M 17M 23M 13M
shortTermDebt 5M 5M 0 9M 9M 4M 0 4M 4M 4M 0 4M 0 26M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 17M 15M 0 0 0 0 0
otherCurrentLiabilities 22M 22M 8M 19M 21M 32M 20M 14M 14M 26M 19M 33M 21M 35M
totalCurrentLiabilities 42M 43M 58M 45M 50M 55M 65M 58M 59M 54M 78M 55M 70M 87M
longTermDebt 115M 134M 93M 99M 108M 84M 82M 96M 103M 103M 68M 55M 50M 72M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 9M 9M 9M 9M 9M 27M 8M 9M 9M 9M 9M 44M 10M 13M
totalNonCurrentLiabilities 124M 143M 119M 108M 117M 111M 109M 105M 112M 112M 92M 65M 70M 94M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 19M 20M 22M 20M 21M 18M 23M 24M 25M 24M 19M 13M 13M 11M
totalLiabilities 166M 185M 176M 153M 167M 166M 175M 163M 171M 166M 170M 120M 140M 181M
preferredStock 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000
commonStock 77 000 77 000 77 000 77 000 77 000 77 000 76 000 76 000 76 000 76 000 75 000 74 000 73 000 72 000
retainedEarnings -834M -847M -824M -782M -779M -776M -764M -745M -741M -748M -735M -701M -692M -737M
accumulatedOtherComprehensiveIncomeLoss 5M 5M 5M 2M 2M 2M 2M 2M 2M 2M 2M -284 000 -284 000 -4M
othertotalStockholdersEquity 1 051M 1 050M 1 044M 1 043M 1 042M 1 041M 1 040M 1 040M 1 036M
totalStockholdersEquity 222M 208M 225M 264M 266M 269M 280M 298M 301M 294M 308M 335M 345M 296M
totalEquity 222M 208M 225M 264M 266M 269M 280M 298M 301M 294M 308M 335M 345M 296M
totalLiabilitiesAndStockholdersEquity 388M 393M 417M 432M 435M 461M 471M 460M 455M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 388M 393M 401M 417M 432M 435M 454M 461M 471M 460M 478M 455M 485M 477M
totalInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalDebt 120M 139M 115M 104M 112M 106M 105M 100M 107M 107M 87M 59M 64M 108M
netDebt 87M 108M 79M 70M 84M 64M 75M 74M 84M 86M 51M 30M 13M 61M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-13 2024-03-14 2023-03-14 2022-03-15 2021-03-26
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 58M 59M 69M 87M 43M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 891 000
totalPayables 20M 21M 28M 23M 13M
otherPayables 0 0 0 0 0
accruedExpenses 24M 20M 27M 21M 11M
capitalLeaseObligationsCurrent 5M 4M 4M 4M 2M
capitalLeaseObligationsNonCurrent 17M 19M 15M 9M 9M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 044M 1 041M 1 041M 1 037M 1 037M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164
fillingDate 2025-11-07 2025-08-08 2024-11-08 2024-08-08 2024-05-08 2023-11-08 2023-08-08 2023-05-09 2022-11-09
acceptedDate 2025-11-07 16:16:19 2025-08-08 16:11:46 2025-03-13 16:15:45 2024-11-08 16:20:26 2024-08-08 16:35:14 2024-05-08 16:15:43 2024-03-14 06:20:03 2023-11-08 16:32:32 2023-08-08 16:16:45 2023-05-09 16:36:10 2023-03-14 16:36:21 2022-11-08 20:38:21 2022-03-14 19:07:48 2021-03-26 16:16:56
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 14M -11M -59M -2M -3M -12M -28M -3M 8M -13M -42M -28M 46M -17M
depreciationAndAmortization 6M 6M 24M 6M 6M 6M 23M 6M 6M 6M 25M 6M 23M 30M
deferredIncomeTax 0 0 0 0 0 0 0 -1M -959 000 0 0 0 0 0
stockBasedCompensation 706 000 626 000 4M 862 000 2M 1M 4M 1M 959 000 752 000 3M 767 000 3M 3M
changeInWorkingCapital 9M 5M 10M 12M -10M 9M 4M 17M 3M -20M 32M -3M -13M 37M
accountsReceivables 3M 8M 562 000 12M -6M 675 000 9M -3M 3M 2M 24M 17M -44M 31M
inventory 2M -4M 4M 1M -2M 9M 12M 14M -4M -519 000 -15M 1M -16M 19M
accountsPayables 5M 838 000 10M -1M -2M -2M -13M 7M 5M -24M 28 115M -9M 0 0
otherWorkingCapital -1M 220 000 -5M -522 000 109 000 691 000 -5M -2M -2M 3M -28 092M -12M 47M -13M
otherNonCashItems -7M -2M 17M 2M 15M 2M 19M 4M -6M 3M -12M 5M -32M 19M
netCashProvidedByOperatingActivities 23M -848 000 -4M 19M -14M 1M 22M 23M 10M -23M 6M -19M 27M 72M
investmentsInPropertyPlantAndEquipment -2M -484 000 -11M -491 000 -5M -5M -30M -7M -8M -10M -38M -15M -16M -7M
acquisitionsNet 0 -2M 0 3M -1M -1M -4M 0 0 -4M -15M -30 000 44M 20M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 -2M -1M -1M 0 0 0 15M
netCashUsedForInvestingActivites -2M -3M -91 000 -6M -6M -7M -8M -13M -735 000
debtRepayment -18M 7M -8M 6M -2M -6M -2M 0 0
commonStockIssued 0 0 0 0 0 0 2M 0 0
commonStockRepurchased 0 0 0 0 0 0 -4M 0 -1M -2M -1M 0 0 0
dividendsPaid -319 000 -315 000 -319 000 -316 000 -315 000 -319 000 -315 000 -312 000 -319 000
otherFinancingActivites 0 0 0 0 2M -6M -2M 15M -22M
netCashUsedProvidedByFinancingActivities -19M 7M -8M 6M 1M -7M -3M 13M -23M
effectOfForexChangesOnCash 0 0 0 0 0 0 0 -8M 15M 0 0 0 0 0
netChangeInCash 3M 3M -9M 10M -14M -3M -4M 10M -1M -23M -13M -42M 14M 29M
cashAtEndOfPeriod 33M 30M 36M 38M 28M 42M 45M 35M 25M 26M 50M 32M 62M 48M
cashAtBeginningOfPeriod 30M 27M 45M 28M 42M 45M 50M 25M 26M 50M 62M 75M 48M 20M
operatingCashFlow 23M -848 000 -4M 19M -14M 1M 22M 23M 10M -23M 6M -19M 27M 72M
capitalExpenditure -2M -484 000 -11M -491 000 -5M -5M -30M -7M -8M -10M -38M -15M -16M -7M
freeCashFlow 21M -1M -15M 18M -18M -3M -8M 16M 2M -33M -32M -34M 10M 65M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-13 2024-03-14 2023-03-14 2022-03-15 2021-03-26
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -2M 0 15M 0 10M
netCashProvidedByInvestingActivities -13M -33M -38M 27M 23M
netDebtIssuance 9M 13M 27M -38M -148M
longTermNetDebtIssuance 9M 0 59M -55M -102M
shortTermNetDebtIssuance 0 13M -32M 18M -46M
netStockIssuance 0 -4M -1M 462 000 76M
netCommonStockIssuance 0 -4M -1M 462 000 76M
commonStockIssuance 0 0 0 462 000 76M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -1M -1M -1M -3M 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid -1M -1M -1M -3M 0
otherFinancingActivities 0 -714 000 -5M 0 6M
netCashProvidedByFinancingActivities 8M 7M 19M -40M -66M
incomeTaxesPaid 0 324 000 2M 448 000 0
interestPaid 0 10M 3M 4M 17M

Earning call transcript

2025 q3
2025-11-05 ET (fiscal 2025 q3)
2025 q2
2025-08-06 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-03-05 ET (fiscal 2024 q4)
2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-08-09 ET (fiscal 2024 q2)
2024 q1
2024-05-06 ET (fiscal 2024 q1)
2023 q4
2024-03-11 ET (fiscal 2023 q4)
2023 q3
2023-11-06 ET (fiscal 2023 q3)
2023 q2
2023-08-07 ET (fiscal 2023 q2)
2023 q1
2023-05-08 ET (fiscal 2023 q1)
2022 q4
2023-03-09 ET (fiscal 2022 q4)
2022 q3
2022-11-07 ET (fiscal 2022 q3)
2022 q2
2022-08-08 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-11-05 16:15 ET
Alto Ingredients reported for 2025 q3
SEC form 8
2025-11-05 16:15 ET
Alto Ingredients published news for 2025 q3
SEC form 10
2025-08-08 16:11 ET
Alto Ingredients reported for 2025 q2
SEC form 8
2025-08-06 20:19 ET
Alto Ingredients reported for 2025 q2
SEC form 8
2025-08-06 20:19 ET
Alto Ingredients published news for 2025 q2
SEC form 10
2025-05-09 20:16 ET
Alto Ingredients published news for 2025 q1
SEC form 10
2025-05-09 00:00 ET
Alto Ingredients published news for 2025 q1
SEC form 8
2025-05-07 20:14 ET
Alto Ingredients published news for 2025 q1
SEC form 8
2025-05-07 20:14 ET
Alto Ingredients reported for 2025 q1
SEC form 10
2025-03-13 20:15 ET
Alto Ingredients published news for 2024 q4
SEC form 10
2025-03-13 00:00 ET
Alto Ingredients published news for 2024 q4
SEC form 8
2025-03-05 16:15 ET
Alto Ingredients published news for 2024 q4
SEC form 8
2025-03-05 16:15 ET
Alto Ingredients reported for 2024 q4
SEC form 10
2024-11-08 16:20 ET
Alto Ingredients published news for 2024 q3
SEC form 8
2024-11-06 16:19 ET
Alto Ingredients published news for 2024 q3
SEC form 8
2024-11-06 16:19 ET
Alto Ingredients published news for 2024 q3
SEC form 10
2024-08-08 00:00 ET
Alto Ingredients published news for 2024 q2
SEC form 8
2024-08-06 16:21 ET
Alto Ingredients published news for 2024 q2
SEC form 8
2024-08-06 16:21 ET
Alto Ingredients reported for 2024 q2
SEC form 10
2024-05-08 00:00 ET
Alto Ingredients published news for 2024 q1
SEC form 8
2024-05-06 16:13 ET
Alto Ingredients published news for 2024 q1
SEC form 8
2024-05-06 16:13 ET
Alto Ingredients reported for 2024 q1
SEC form 10
2024-03-14 06:20 ET
Alto Ingredients published news for 2023 q4
SEC form 10
2024-03-14 00:00 ET
Alto Ingredients published news for 2023 q4
SEC form 8
2024-03-11 16:18 ET
Alto Ingredients published news for 2023 q4
SEC form 8
2024-03-11 16:18 ET
Alto Ingredients reported for 2023 q4
SEC form 10
2023-11-08 00:00 ET
Alto Ingredients published news for 2023 q3
SEC form 8
2023-11-06 16:19 ET
Alto Ingredients reported for 2023 q3
SEC form 10
2023-08-08 16:16 ET
Alto Ingredients published news for 2023 q2
SEC form 10
2023-08-08 00:00 ET
Alto Ingredients published news for 2023 q2
SEC form 6
2023-08-07 16:15 ET
Alto Ingredients reported for 2023 q2
SEC form 8
2023-08-07 00:00 ET
Alto Ingredients published news for 2023 q2
SEC form 6
2023-06-22 16:26 ET
Alto Ingredients published news for 2023 q1
SEC form 10
2023-05-09 00:00 ET
Alto Ingredients published news for 2023 q1
SEC form 8
2023-05-08 00:00 ET
Alto Ingredients published news for 2023 q1
SEC form 10
2023-03-14 00:00 ET
Alto Ingredients reported for 2022 q4
SEC form 8
2023-03-09 00:00 ET
Alto Ingredients reported for 2022 q4
SEC form 10
2022-11-09 00:00 ET
Alto Ingredients reported for 2022 q3
SEC form 8
2022-11-07 00:00 ET
Alto Ingredients reported for 2022 q3
SEC form 10
2022-08-09 00:00 ET
Alto Ingredients reported for 2022 q2
SEC form 8
2022-08-08 00:00 ET
Alto Ingredients reported for 2022 q2
SEC form 10
2022-05-10 00:00 ET
Alto Ingredients reported for 2022 q1
SEC form 8
2022-05-09 00:00 ET
Alto Ingredients reported for 2022 q1
SEC form 10
2022-03-15 00:00 ET
Alto Ingredients published news for 2021 q4
SEC form 8
2022-03-10 00:00 ET
Alto Ingredients published news for 2021 q4
SEC form 10
2021-11-12 00:00 ET
Alto Ingredients published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Alto Ingredients published news for 2021 q3
SEC form 10
2021-08-10 00:00 ET
Alto Ingredients published news for 2021 q2
SEC form 10
2021-05-17 00:00 ET
Alto Ingredients published news for 2021 q1